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ABSTRACT  
Background: Although psychological treatments for social anxiety disorder (SAD) can be highly effective, 
many individuals do not respond to treatment. Identifying factors associated with improved outcomes 
can facilitate individualized treatment choices. We investigated whether patterns of neural connectivity 
predicted treatment responses and whether treatment type, cognitive behavioral therapy (CBT) or 
acceptance and commitment therapy (ACT), moderated this effect.  
Methods: Participants with SAD (n=34) underwent fMRI prior to treatment and completed implicit and 
explicit emotion regulation tasks. Neural connectivity measures were estimates of amygdala-prefrontal 
cortex connectivity. Treatment responder status was defined using the ‘clinically significant change index’ 
(Loerinc et al., 2015).  
Results: Right amygdala-right ventrolateral prefrontal cortex connectivity during implicit emotion 
regulation was a significant predictor of treatment response (OR = 9.01, 95% CI = 1.77, 46.0, p = .008). 
Stronger inverse connectivity was associated with greater likelihood of treatment response. There were 
no significant neural moderators of treatment response to CBT versus ACT.  
Limitations: The primary limitation of this work was the small sample size which limited the power to 
detect significant moderation effects, and results should be interpreted as preliminary.  
Conclusions: Amygdala-vlPFC connectivity during affect labeling predicted treatment responder status 
following CBT or ACT for social anxiety disorder. This suggests that the functioning of neural circuitry 
supporting emotion regulation capacities may be a ‘gateway’ to receiving benefit from psychological 
treatments. Future work should aim to replicate this effect in a larger sample and consider methods for 
enhancing functional connectivity within this circuitry as a potential treatment adjunct. 
Introduction 
Although psychological treatments for social anxiety disorder (SAD) can be highly effective for some 
individuals, a large number of patients (as many as 55%; Loerinc et al., 2015) fail to respond to treatment, 
or retain residual symptoms or impairment following treatment. The ability to predict which individuals 
are likely to respond to which treatments not only informs individual treatment choices, but also 
elucidates the mechanisms of treatments themselves. Existing work in this domain has begun to identify 
a set of characteristics, determined by self-report, clinician assessment or task performance, that are 
predictive of responses to Cognitive Behavioral Therapy (CBT) for anxiety disorders (Schneider et al., 
2015). Here, we extend this approach to identify neural indices that predict treatment response, an 
approach which can help to enhance our understanding of the effects of psychological treatment on the 
brain (Craske, 2014; Holmes et al., 2014). 
 
Previous work investigating the neurobiological basis of anxiety disorders has highlighted disruptions in 
emotion regulation neural circuitry. The neurobiological model of emotion regulation states that reactivity 
to emotional stimuli in the amygdala is regulated through top-down connectivity with regions of the 
prefrontal cortex (PFC; Brühl et al., 2014; Goldin et al., 2009b; Ochsner and Gross, 2005; Zilverstand et al., 
2016; Ziv et al., 2013). Supporting this model, previous work has demonstrated that, compared to healthy 
individuals, patients with SAD show: i) disrupted activation in the amygdala and regions of the prefrontal 
cortex (for reviews, see Berkman and Lieberman, 2009; Freitas-Ferrari et al., 2010; Kim et al., 2011) and 
ii) altered amygdala connectivity with vlPFC (Burklund et al., 2014a), dlPFC (Goldin et al., 2009a), vmPFC 
(Hahn et al., 2011; Sladky et al., 2015; Young et al., 2017) and dACC/mPFC (Demenescu et al., 2013). 
Emerging evidence implicates this circuitry in mechanisms of treatment response, with studies 
demonstrating altered connectivity following CBT between amygdala and dmPFC, mOFC and vl/dlPFC 
(Goldin et al., 2013; Goldin et al., 2014; Månsson et al., 2013). In addition, we previously demonstrated 
that SAD symptom reduction following either CBT or Acceptance and Commitment Therapy (ACT; another 
form of behavioral therapy) was associated with enhanced inverse connectivity between vmPFC/vlPFC 
and amygdala during implicit emotion regulation (Young et al., 2017).  
 
If, as these findings suggest, treatment for SAD works through altering connectivity within the neural 
circuits associated with emotion regulation, then an individual’s pre-treatment connectivity may impact 
their likelihood of responding to treatment. No prior studies have assessed the role of emotion regulation 
in predicting treatment response. Most existing studies have assessed pre-treatment measures of neural 
activation rather than connectivity and focused on emotional reactivity, rather than regulation. These 
studies have demonstrated that greater symptom reduction following CBT was associated with greater 
pre-treatment neural responses to emotional stimuli (emotional faces or rejecting statements) within the 
anterior cingulate cortex (ACC), dm/vmPFC and areas of occipital and parietal lobe (dACC and dmPFC; 
Burklund et al., 2017; Doehrmann et al., 2013; Klumpp et al., 2014; Klumpp et al., 2013). The role of 
amygdala activation in predicting treatment response remains unclear. Symptom reduction was predicted 
by decreased pre-treatment amygdala reactivity in one study (Klumpp et al., 2014) and increased 
reactivity in another (Burklund et al., 2017).  
 
Of the two prior studies incorporating connectivity measures, one demonstrated that long-term (1 year) 
outcomes following internet-delivered CBT for SAD were predicted by decreased pre-treatment 
amygdala-dACC connectivity during a self-referential criticism task (Månsson et al., 2015). The other, using 
resting state functional connectivity, found that greater symptom reduction following CBT for SAD was 
associated with stronger pre-treatment amygdala-ACC connectivity, stronger amygdala connectivity with 
caudate and putamen, and reduced amygdala connectivity with central sulcus and right temporo-occipital 
cluster. This study additionally found that greater inferior longitudinal fasciculus (ILF) density (the white 
matter tract connecting amygdala with early visual areas) prior to treatment predicted greater symptom 
reduction following treatment (Whitfield-Gabrieli et al., 2016). In general, these findings support a role 
for activation and connectivity among neural circuitry involved in emotional processing in predicting 
treatment response, albeit with specific directions and locations of effects varying across task design.  
 
In the current study, we build on this work by addressing two key limitations. First, we assessed neural 
functional connectivity during emotion regulation, a treatment-relevant process. Both CBT and ACT focus 
on improving emotion regulation, albeit through different approaches. CBT teaches ‘reappraisal’, the 
intentional re-framing of negative or unpleasant thoughts or experiences (Craske, 2010). ACT promotes 
‘acceptance’, the acknowledgement that emotional experiences are fleeting and can be viewed with a 
sense of perspective (Hayes et al., 1999). Measuring neural connectivity during emotion regulation allows 
a more direct investigation of whether treatment-relevant processes predict treatment response (Young 
and Craske, 2018). Second, previous studies have primarily correlated responses with self-reported 
symptoms following treatment, or categorized ‘treatment-responders’ as those showing greatest 
symptom reduction. A more robust measure of treatment response can be obtained through use of a 
‘clinically significant change index’ (CSCI) (Loerinc et al., 2015). This approach requires that, in order to be 
classified as a ‘treatment responder’, an individual must: i) demonstrate a statistically significant reduction 
in symptoms, and ii) move below threshold for clinical cut-offs in an independent diagnostic evaluation.  
 
The current study aimed to investigate whether connectivity among emotion regulation neural circuitry 
(amygdala-prefrontal cortex) predicts whether patients with SAD are likely to respond to treatment. A 
secondary aim was to investigate differential predictors for treatment responses to CBT or ACT.  
 
Methods 
Participant details 
Full details of the randomized controlled trial for SAD comparing CBT, ACT and a wait-list control group 
are described elsewhere (Craske et al., 2014). Participants were recruited from flyers, internet and 
newspaper advertisements and referrals. Procedures were approved by the UCLA Office for the Protection 
of Human Research Subjects and participants provided informed consent. Participants were aged 18-45 
years, English speaking, right-handed, and had a diagnosis of SAD. Exclusion criteria were: history of 
bipolar disorder, substance-use disorders, suicidality, psychosis or psychiatric hospitalizations; recent 
modifications to psychotropic medications (within past month for benzodiazepines, past 3-months for 
SSRIs/SNRIs and heterocyclics); current cognitive or behavioral psychotherapy for an anxiety disorder or 
recent modifications to other psychotherapies (within past 6 months); and standard MRI 
contraindications (pregnancy, claustrophobia, non-removable metal). Data analyzed here included 34 
participants, 17 who subsequently received CBT and 17 who received ACT (see Supplemental Materials 
for Consort diagram, full details on participant inclusion and treatment overview). Table 1 presents 
demographic details of participants. 
Assessment measures 
Diagnostic evaluations were conducted using the Anxiety Disorders Interview Schedule-IV (ADIS IV; Brown 
et al., 1994) by trained interviewers. Included participants met DSM-IV criteria for current, principal or co-
principal diagnosis of SAD, with a clinical severity rating (CSR) of 4 or higher, indicating clinically significant 
severity. Symptom severity was assessed using a composite of the total scores of three self-report 
measures: the Liebowitz Social Anxiety Scale–Self-Report Version, a 24-item measure assessing fear and 
avoidance of social interactions and performance situations (LSAS-SR; Fresco et al., 2001); the Social 
Interaction Anxiety Scale, a 20-item measure of cognitive, affective and behavioral reactions to social 
interaction (SIAS; Mattick and Clarke, 1998); and the Social Phobia Scale, a 20-item measure describing 
responses to situations or themes related to being observed by others (SPS; Mattick and Clarke, 1998). A 
composite score was created from the LSAS, SIAS, and SPS to generate a reliable and valid index of social 
anxiety symptoms (consistent with the main outcome paper for this study; Craske et al., 2014). Z-scores 
were calculated for each measure at pre-treatment, and standardization was based on pre-treatment 
means and standard deviations for each subsequent assessment (see Craske et al., 2014 for details). The 
composite score represented averages of the three measures. In four cases where SIAS and SPS data were 
missing, self-report scores were based on LSAS data. 
fMRI data acquisition 
Participants completed an affect labeling task (a measure of implicit emotion regulation; Burklund et al., 
2014b) and an explicit emotion regulation task (measuring responses during regulation of social cues; 
Burklund et al., 2017). See Supplemental Materials for details on MRI acquisition and preprocessing. 
Implicit emotion regulation task 
In the affect labeling task, participants viewed a series of images of emotional facial expressions and 
geometric shapes and were asked to complete labeling and matching tasks (affect labeling, gender 
labeling, affect matching and shape matching). In labeling conditions, participants responded via button 
press to select which of two words best match the affect or gender of the face displayed (match conditions 
require selection of matching images rather than matching words). The current study focused on 
assessment of implicit emotion regulation capacity, as indexed by the contrast of affect label versus 
gender label. Stimuli were presented in a blocked design, with four blocks of each condition and six trials 
per block (30s block, 5s per trial, order counterbalanced across participants). Each block was preceded by 
a 10s fixation cross and a 3s instruction cue. 
Explicit emotion regulation task 
Participants viewed blocks of video clips from actors saying rejecting, neutral, or positive phrases. They 
were instructed to imagine that the people in the videos were speaking directly to them. For rejecting 
videos, participants were asked either to passively “watch” the video, “reappraise by trying to reduce your 
emotional response”, or “accept by noticing how you are responding”. The current study focused on 
assessment of: i) explicit ‘CBT-like’ emotion regulation (reappraisal vs. passive viewing of rejecting videos) 
and ii) explicit ‘ACT-like’ emotion regulation (acceptance vs. passive viewing of rejecting videos). 
Participants also viewed videos of positive statements and inanimate objects as other control conditions. 
Stimuli were presented in a blocked design, with two blocks of each condition type and six trials per block 
(30s block, 5s per trial, order counterbalanced across participants). Each block was preceded by a 5s 
instructional cue, followed by 11s rating period (during which participants provided ratings of perceived 
distress, not analyzed here) and a 10s fixation cross. 
Data analysis 
Clinically significant change index  
CSCI (Loerinc et al., 2015) was calculated based on a combination of reliable change index on the SAD 
symptom composite (described above) and a clinical cut-off on the ADIS-IV. Treatment responders were 
individuals who achieved both: i) reliable change in self-reported symptomatology on the symptom 
composite and ii) movement into the non-clinical range of CSRs on the ADIS-IV (a CSR of below 4). The 
cutoff for reliable change was calculated as the difference between the pre-treatment and post-treatment 
scores across the whole sample, divided by the standard error of the difference between the two scores 
(Jacobson and Truax, 1991). If an individual’s score exceeded the cutoff value, it was classified as a reliable 
change. Non-responders were defined as those who did not achieve a reliable reduction in symptom level 
and/or did not move below the threshold for clinically-significant CSR. 
fMRI connectivity analyses 
Psychophysiological interaction (PPI) analyses were conducted to assess task-related changes in functional 
connectivity of left and right amygdala seed regions (generalized PPI toolbox for SPM; McLaren et al., 
2012). Amygdala seed regions were defined on the basis of anatomical masks (Automated Anatomical 
Labelling; AAL). Prefrontal cortical regions of interest (ROIs) were functionally-defined using an automated 
meta-analytic tool (Neurosynth; www.neurosynth.org; Yarkoni et al., 2011) using the search term 
‘emotion regulation’. The resulting ‘forward inference’ map was parsed into prefrontal clusters: 
ventromedial PFC (vmPFC), right and left ventrolateral PFC (rvlPFC and lvlPFC; see Figure 1A). Parameter 
estimates (β values) were extracted for each ROI using the Marsbar toolbox for SPM (Brett et al., 2002).  
Statistical analyses 
To test amygdala-PFC connectivity as moderators (i.e., CBT vs ACT) and predictors (i.e., CBT and ACT 
collapsed) of treatment response, we used logistic regression. Connectivity estimate outliers (defined as 
greater than 2.5 standard deviations above/below the mean) were removed from analyses (n=2 for right 
amygdala-rvlPFC connectivity). For the moderator analysis, variables in the model were amygdala-PFC 
connectivity (3 PFC ROIs, 3 task conditions), treatment group, and the connectivity × treatment group 
interactions. We examined the significance of the interactions. If the moderator analysis was not 
significant, we removed the interaction from the model and examined significance of the connectivity 
main effect. To estimate the predictive value of the regression model for unseen data, we used leave-one-
out k-fold cross validation. This approach provides an estimate of utility of the regression model for 
predicting treatment response among participants whose data were not used to estimate the regression 
model.  In leave-one-out k-fold cross validation, all participants except one are used to fit the model, then 
the model is used to predict the out-of-sample participant’s outcome category. This is then iterated for 
each participant and used to predict probability of response across the full sample. Accuracy, sensitivity, 
and specificity can then be calculated by comparing the predicted probabilities estimated from the k-fold 
cross validation procedure to actual outcome (i.e. response or non-response). 
 
Results 
Treatment outcomes 
Of the 34 participants included in the analyses, 16 achieved clinically significant change on the CSCI, 18 
did not. Response rates were comparable across treatment conditions with eight participants in each 
group achieving responder status. Of the non-responders, none of the participants moved into the non-
clinical diagnostic range on the ADIS (all retained a CSR ≥ 4), although 9 (3 CBT, 6 ACT) achieved significant 
reductions in self-reported symptomatology on the symptom composite measure. 
Predictors of treatment outcomes 
Implicit emotion regulation task: In the moderator analyses, none of the connectivity x treatment group 
interactions were significant (all p > .050). For the predictor analysis, right vlPFC-right amygdala 
connectivity predicted clinically significant treatment response such that greater inverse connectivity was 
associated with better treatment responding regardless of treatment condition (OR = -9.01, 95% CI = -
1.77, -46.0, p = .008; see Figure 1B).  Based on the k-fold cross validation results, right vlPFC-right amygdala 
connectivity classified participants as treatment responders or not (using ≥ .5 probability as predicting 
treatment response and < .5 probability as non-response) with 69% accuracy, 67% sensitivity, and 71% 
specificity. No other connectivity measures were significant predictors of treatment response (all p > .05). 
Explicit emotion regulation task: There were no significant connectivity x treatment group interactions in 
moderator analyses and no significant connectivity main effects in predictor analyses on this task (all p > 
.05). 
Discussion 
Results demonstrated that stronger inverse connectivity between right amygdala and right vlPFC during 
implicit emotion regulation was associated with a greater likelihood of subsequent response to 
psychological treatment for SAD, regardless of treatment condition. In cross-validation analysis this 
connectivity estimate was found to predict treatment response with 69% accuracy. None of the neural 
connectivity estimates assessed were significant moderators of treatment response, predicting greater 
likelihood of response to CBT or ACT individually.  
Previous work has demonstrated regions of activation or patterns of connectivity in response to emotional 
stimuli (i.e., emotional reactivity) that predict treatment response. Here we present the first findings, to 
our knowledge, that demonstrate how patterns of connectivity during emotion regulation predict 
treatment outcome. Given that current psychological treatments for SAD focus on emotion regulation 
skills, these analyses directly reflect how baseline capacity in treatment-relevant processes relates to 
treatment outcomes. Studies of emotional reactivity have highlighted the predictive value of activation in 
ACC, mPFC and occipital regions as well as connectivity between amygdala and ACC, caudate, putamen, 
central sulcus, and temporo-occipital regions (Burklund et al., 2017; Doehrmann et al., 2013; Klumpp et 
al., 2014; Klumpp et al., 2013; Månsson et al., 2015; Whitfield-Gabrieli et al., 2016). This implicates a broad 
network of regions in which reactivity might be related to treatment outcome. One previous study 
demonstrated prediction of CBT treatment response, defined solely by symptom reduction, at 81% 
accuracy using a combination of measures across diffusion MRI, resting state amygdala connectivity and 
multi-voxel pattern analysis (Whitfield-Gabrieli et al., 2016). Here we demonstrate prediction of clinically 
significant treatment response at 69% accuracy using a single, theoretically-driven index of connectivity 
in emotion regulation neural circuitry. This effect was specific to right amygdala-right vlPFC connectivity 
during implicit emotion regulation predicting response to treatment for social anxiety disorder (combining 
CBT and ACT).  
Inverse prefrontal-amygdala connectivity has been highlighted as an index of emotion regulatory capacity 
whereby activation of prefrontal regions is thought to facilitate ‘down-regulation’ of amygdala responses 
(Ochsner et al., 2012). Our findings suggest that those better able to effectively engage this circuitry during 
implicit emotion regulation at baseline are more likely to achieve better outcomes from behavioral 
treatment. This effect was observed when collapsing across CBT and ACT groups and was specific to 
implicit emotion regulation (affect labeling). We did not observe any predictive or moderation effects of 
connectivity during explicit regulation (reappraisal or acceptance). While both tasks measure emotion 
regulation, they differ in intentionality. The goal of reappraisal or acceptance (explicit task) is to 
intentionally reduce emotional reactivity, while affect labeling simply involves recognizing an emotional 
cue, a more incidental form of regulation (Burklund et al., 2014b). We suggest that connectivity during 
affect labeling reflects a generalized tendency to engage regulatory circuitry when faced with emotional 
stimuli, whereas connectivity during explicit regulation reflects intentional engagement of this circuitry.  
Alternatively, it is plausible that differences in cognitive load between the affect labeling and explicit 
regulation tasks impacted engagement of regulatory circuitry. In the affect labeling task, participants 
choose which of two words best describes the emotion in the face presented, a low cognitive load. In the 
explicit regulation task, participants are instructed to construct their own reappraisal or acceptance of 
negative statements, requiring a higher demand on cognitive capacities. A recent study demonstrated 
that regulatory neural connectivity (orbitofrontal cortex to amygdala functional connectivity) was 
modulated by the level of cognitive load (using a Stroop task; Minkova et al., 2017). Comparing individuals 
with SAD to healthy individuals, deficits in regulatory connectivity were observed only when cognitive 
load was low. There were no group differences observed in the high cognitive load condition, suggesting 
that regulatory capacity was impacted by attentional demands for all individuals. Therefore, the additional 
cognitive load of the explicit regulation task may reduce regulatory capacity among all individuals, masking 
individual differences in the tendency to engage regulatory circuitry. Future comparison of these 
possibilities would be of much interest, particularly given that the cognitive load of reappraisal and 
acceptance is likely reduced following treatment, where these skills are extensively practiced. 
Nonetheless, our results suggest that only the extent to which emotion regulation neural circuitry is 
incidentally engaged (during low cognitive load) is predictive of subsequent treatment response. In 
previous work, we demonstrated that enhanced inverse connectivity within this circuitry was associated 
with symptom reduction following treatment, collapsing across CBT and ACT groups (Young et al., 2017). 
Together, this would suggest a ‘building on strengths’ model (Engebretson et al., 1989; Rude and Rehm, 
1991), such that individuals with greater capacity to implicitly regulate their emotions may benefit more 
from psychological treatment. 
Given that CBT teaches reappraisal-based emotion regulation and ACT teaches acceptance-based 
regulation, the explicit emotion regulation task allowed direct assessment of treatment-relevant 
mechanisms. It might be expected that connectivity during reappraisal would predict treatment responses 
to CBT and connectivity during acceptance would predict treatment response to ACT. However, this 
moderation effect was not significant in the current analyses. It is plausible that there are treatment-
specific differences in activation or connectivity outwith the primary network of emotion regulation 
neural circuitry investigated here. However, it should be noted that the current sample size may be too 
small to sufficiently assess treatment-moderator effects and that with a larger sample, neural moderators 
of treatment response may be observed. 
Methodological strengths  
This study has a number of methodological strengths that build upon findings from previous work. First, 
data were collected in the context of a high-quality randomized controlled trial using manualized 
treatment interventions with a high level of therapist adherence to protocol and validity in assessment 
methods (Craske et al., 2014). Second, the use of the CSCI as a measure of treatment responder status 
provides a reliable and conservative index, ensuring a clinically meaningful definition of this term. It should 
be noted that whereas other studies have reported higher response rates to CBT for SAD, the response 
rate in this study (47%) is typical when a CSCI is used (Loerinc et al., 2015).  
Limitations 
The primary limitation of this work was the sample size, although it is consistent with prior studies in this 
field (Doehrmann et al., 2013; Whitfield-Gabrieli et al., 2016). We had limited power to detect significant 
moderators of treatment response, such as baseline capacity to engage emotion regulation neural 
circuitry during instructed reappraisal predicting better outcomes to CBT over ACT. In addition, we used 
a ‘treatment completer’ analysis, rather than an ‘intent-to-treat’ analysis, which has been criticized due 
to the exclusion of data from individuals who did not fully comply or did not complete treatment (Gupta, 
2011).  
Future directions 
Although it is not currently feasible to incorporate functional MRI assessments into standard clinical care, 
this evidence highlights the relevance of emotion regulation neural circuitry in individual responses to 
treatment conditions. Future work might consider what characteristics of the non-responder group might 
be better targeted in future treatment. Other methods of enhancing functional connectivity within this 
neural circuitry might also be investigated (e.g., transcranial direct current stimulation; Kuo et al., 2014) 
which may be particularly effective for individuals with low baseline connectivity. In addition, future 
studies should employ larger samples to permit more highly powered analyses of treatment moderators.  
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Table 1. Demographic and diagnostic details of included participants (LSAS: Liebowitz Social Anxiety Scale; 
SIAS: Social Interaction Anxiety Scale; SPS: Social Phobia Scale) 
 
CBT ACT Full sample 
N 17 17 34 
 
Male 8 7 15 
 
Female 9 10 19 
 
Age: M (SD) 26.29 (6.20) 26.88 (5.07) 26.59 (5.67) 
Responder Status 
   
 
Responder 8 8 16 
 
Non-responder 9 9 18 
Race/ethnicity 
   
 
White (Non-Hispanic/Latino) 9 10 19 
 
Asian/Asian-American 4 2 6 
 
Hispanic/Latino  2 3 5 
 
Multiracial/Other race not specified 2 2 4 
Baseline symptom scores    
 
Symptom composite: M (SD) -0.07 (0.62) 0.00 (0.83) -0.01 (0.73) 
 
LSAS: M (SD) 79.94 (17.57) 85.41 (19.83) 80.33 (23.15) 
 
SIAS: M (SD) 51.94 (11.51) 51.29 (11.65) 50.11 (14.27) 
 
SPS: M (SD) 33.38 (10.95) 33.18 (12.40) 32.32 (12.96) 
 
 
 
  
Figure 1. A) Prefrontal cortex regions of interest for connectivity analyses, obtained using Neurosynth 
displaying right and left vlPFC (red and blue) and vmPFC (green). B) Probability of treatment response 
(CBT and ACT collapsed) predicted from right vlPFC-right amygdala connectivity (positive numbers 
indicate positive connectivity and negative numbers indicate negative connectivity) 
 
 
 
